Results 41 to 50 of about 2,280,070 (229)

The use of anti-tuberculosis therapy for latent TB infection [PDF]

, 2010
Justin T Denholm1,2, Emma S McBryde1,21Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia; 2Department of Medicine, (RMH/WH), University of Melbourne, Parkville, Victoria, AustraliaAbstract: Tuberculosis ...
Denholm, Justin T., McBryde, ES, Emma S McBryde, Justin T Denholm, McBryde, Emma S., Denholm, JT, Justin Denholm   +6 more
core   +1 more source

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

Arthritis Care &Research, EarlyView.
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin, Candace H. Feldman, Claire E. H. Barber, Gabriel Fabreau, Jake Jennings, Scott Patten, Cheryl Barnabe, Inflammatory Arthritis‐Specific ACSC Consensus Process Working Group   +7 more
wiley   +1 more source

Tuberculosis contact tracing among children and adolescent referred to children's hospital in Rio de Janeiro, Brazil

Brazilian Journal of Infectious Diseases, 2015
Objective: To describe the investigation of latent tuberculosis infection and indication for isoniazid preventive therapy in children and adolescents evaluated at the children's hospital. Methods: This retrospective study examines all latent tuberculosis
Angela Marcia Cabral Mendonça, Afrânio Lineu Kritski, Clemax Couto Sant’Anna   +2 more
doaj   +1 more source

Incidence, Risk Factors and Management of Adverse Events in Contemporary Real‐World Care of Children with Juvenile Idiopathic Arthritis

Arthritis Care &Research, Accepted Article.
Objective We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAE and SAE) in children with newly diagnosed Juvenile Idiopathic Arthritis (JIA) in Canada. Methods We enrolled patients within 3 months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry,
Bashayer Alnuaimi, Roberta A. Berard, Jean‐Philippe Proulx‐Gauthier, Heinrike Schmeling, Michelle Batthish, Gilles Boire, Adam M. Huber, Dax G. Rumsey, Jaime Guzman, Gaëlle Chédeville, The CAPRI registry Investigators   +10 more
wiley   +1 more source

Association between hematological inflammatory markers and latent TB infection: insights from NHANES 2011–2012 and transcriptomic data

Frontiers in Cellular and Infection Microbiology
BackgroundLatent tuberculosis infection affects about one-quarter of the global population and can progress to active tuberculosis. Hematological inflammatory markers, such as the systemic immune-inflammation index, neutrophil-to-lymphocyte ratio ...
Yang Liu, Chunyan He, He Zhao, Weiyao Zhong, Shihua Sun, Zhuo Li, Jingwei Shi   +6 more
doaj   +1 more source

Gene expression in peripheral blood cells for differentiation of active and latent tuberculosis infection in children and adolescents

Туберкулез и болезни лёгких, 2020
The objective: to analyze the expression of certain genes in the blood cells of children and adolescence to differentiate the active and latent phases of tuberculosis infection.Subjects and methods.
A. A. Elov, M. A. Vladimirskiy, S. V. Smerdin, O. I. Elufimova   +3 more
doaj   +1 more source

Immunological assays in the diagnosis of tuberculosis infection at the beginning of 21st century [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2010
A subject infected by tubercle bacilli may immediately develop the disease (primary tuberculosis), witch occurs in a few number of infected persons, or may overcome the primary infection (a latent carrier of the infection).
Kašiković-Lečić Svetlana, Pavlović Slobodan, Kuruc Vesna, Ilić Miroslav   +3 more
doaj   +1 more source

Screening for tuberculosis of patients with HIV-infection. New possibilities

Acta Biomedica Scientifica, 2022
Background. Tuberculosis associated with HIV infection is becoming almost a new disease, where not only new approaches to treatment are being formed, but there is also a need to improve the quality and search for new means of early diagnosis of ...
E. A. Borodulina, D. A. Kudlay, A. N. Kuznetsova   +2 more
doaj   +1 more source

Pharmacokinetics of Rifapentine and Desacetyl Rifapentine in Maternal Plasma and Breast Milk & Infant Cord Blood and Plasma: A Model‐Based Analysis of Mother–Infant Pairs for Tuberculosis Prevention

Clinical Pharmacology &Therapeutics, EarlyView.
IMPAACT 2001 (NCT02651259) evaluated the safety and pharmacokinetics (PK) of once‐weekly isoniazid and rifapentine in pregnant and postpartum women for tuberculosis prevention. Rifapentine (RPT) and desacetyl rifapentine (desRPT) PK data were collected in maternal plasma, breast milk, infant cord blood, and infant plasma.
Priya Jayachandran, Jyoti S. Mathad, Nan Zhang, Paula Britto, Lubbe Wiesner, Grace Montepiedra, Jennifer Norman, Ellen Townley, Sarah Bradford, Sandesh Patil, Stephanie Popson, Tsungai Chipato, Vanessa Rouzier, Deborah Langat, Amphan Chalermchockcharoentkit, Amita Gupta, Kelly E. Dooley, Radojka Savic, on behalf of the IMPAACT 2001 Study Team   +18 more
wiley   +1 more source

Latent Tuberculosis Infection Diagnosis and Treatment

, 2021
This book chapter provides an overview over the latent tuberculosis infection (LTBI) testing and treatment. It provides details of the currently available immunological diagnostic tests, as well as LTBI treatment, referring to the best available evidence
Alberto Matteelli, Altass, L, Matteelli, A, Judith Bruchfeld, Zenner, D, Lynn Altass, Dominik Zenner, Bruchfeld, J, Kunst, H, Heinke Kunst   +9 more
core   +1 more source